Researchers demonstrated AI could detect early laryngeal cancer from voice recordings, distinguishing it from benign conditions.
Key Details
- 1Laryngeal cancer affects over 1 million people worldwide, with high mortality rates.
- 2Diagnosis currently requires invasive endoscopy and biopsy; voice-based screening could simplify detection.
- 3The study analyzed 12,523 voice samples from 306 participants using the Bridge2AI-Voice dataset.
- 4Significant differences in acoustic features, especially harmonic-to-noise ratio, identified laryngeal cancer in men.
- 5Findings suggest voice could serve as a practical biomarker for cancer risk assessment, pending further validation.
Why It Matters
A non-invasive, AI-based screening tool for laryngeal cancer could enable earlier detection, reducing diagnostic delays and easing burden on specialists. This advances the potential of digital biomarkers and broadens the scope of imaging AI in oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.
•EurekAlert
Molecular Test BiliSeq Greatly Improves Bile Duct Cancer Detection
The BiliSeq molecular test developed at UPMC doubled detection sensitivity for bile duct cancer compared to standard pathology.